BSE filing, NSE: VENUSREM. Summary written from the filing by ALFA Finder's alert engine.
Venus Remedies Ltd: key numbers
- Share price
- ₹1,303.60
- Market cap
- ₹1,743 Cr
- Revenue (annual)
- ₹769.6 Cr
- Net profit (annual)
- ₹102.8 Cr
- P/E (TTM)
- 14.3×Sector 46.1×
- Promoter holding
- 41.76%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venus Remedies Ltd
All →Venus Remedies Q2 FY27 Results: Net Profit ₹25.6 Cr, Up 27.4% YoY
Venus Remedies Ltd reported revenue from operations of ₹218.8 Cr (+13.5% YoY) and net profit of ₹25.6 Cr (+27.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.6 Cr · +27.4% YoY
Venus Remedies Regulatory Approval
Venus Remedies Limited secured five marketing authorizations for drugs including Vancomycin and Meropenem across Kazakhstan, Peru, Kuwait, and Argentina. These regulatory approvals expand its global pharmaceutical portfolio.
Venus Remedies Other Announcement
Venus Remedies Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Venus Remedies Other Announcement
Venus Remedies Limited has announced a change in its Corporate Identification Number (CIN) following the alteration of its Memorandum of Association.
Venus Remedies Other Announcement
Venus Remedies Limited has informed the exchanges about its social media posts regarding a special window for the re-lodgement of physical share transfer requests.
Venus Remedies Management Change
Venus Remedies Ltd announced the appointment and re-appointment of several Directors, including Executive and Independent Directors, following approval at its 37th Annual General Meeting.
Other board meeting date announcements
All →Panasonic Energy India Company Board Meeting Date
Panasonic Energy India schedules a board meeting on 5 November 2026 to approve unaudited quarterly and six-month results. Trading window stays closed until 48 hours after the results declaration.
Torrent Power Board Meeting Date
Torrent Power schedules a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for Q2 and half year. The notice carries no financial figures.
Vascon Engineers Board Meeting Date
Vascon Engineers has scheduled a board meeting on November 3, 2026 for quarterly results and NCD fund raising. Trading window stays closed until results are declared.
Ruchi Infrastructure Board Meeting Date
Ruchi Infrastructure schedules a board meeting on 4 November 2026 to approve unaudited quarterly and half-year results. Trading window remains closed until 6 November 2026.
Swastika Castal Board Meeting Date
Swastika Castal will hold a board meeting on 4 November 2026 to consider unaudited results for period ended 30 September 2026. Trading window stays closed until results.
GTL Board Meeting Date
GTL Ltd will hold a board meeting on 5 November 2026 to consider unaudited results for quarter ended 30 September 2026. Results are proposed until the meeting.